Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $133036.0.

  • Immucell's Change in Accured Expenses rose 31035.36% to $133036.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$197037.0, marking a year-over-year decrease of 13081.19%. This contributed to the annual value of $362606.0 for FY2024, which is 13096.66% up from last year.
  • Immucell's Change in Accured Expenses amounted to $133036.0 in Q3 2025, which was up 31035.36% from $225519.0 recorded in Q2 2025.
  • Immucell's 5-year Change in Accured Expenses high stood at $430259.0 for Q2 2024, and its period low was -$531203.0 during Q1 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was $19980.0 (2024), whereas its average is $49175.1.
  • The largest annual percentage gain for Immucell's Change in Accured Expenses in the last 5 years was 31035.36% (2025), contrasted with its biggest fall of 275867.37% (2025).
  • Quarter analysis of 5 years shows Immucell's Change in Accured Expenses stood at $367502.0 in 2021, then dropped by 12.31% to $322265.0 in 2022, then dropped by 21.65% to $252488.0 in 2023, then tumbled by 109.66% to -$24389.0 in 2024, then soared by 645.48% to $133036.0 in 2025.
  • Its Change in Accured Expenses stands at $133036.0 for Q3 2025, versus $225519.0 for Q2 2025 and -$531203.0 for Q1 2025.